Can Gout Cause a Bacterial Infection?

Gout does not directly cause bacterial infections the way a virus or bacterium would, but it creates conditions that make infections considerably more likely. People with gout are roughly two and a half times more likely to develop a joint infection than people without it, and the risk climbs further when large urate deposits called tophi break through the skin and give bacteria a direct route inside.¹ The connection between gout and infection turns out to be more varied, and more dangerous, than most people realize.

How Tophi Break Down the Skin Barrier

The most straightforward route from gout to infection involves tophi, the chalky deposits of urate crystals that form under the skin in long-standing or poorly controlled gout. Over months or years, tophi can grow large enough to press outward through the skin, thinning and eventually ulcerating it. Once the skin barrier is breached, bacteria from the environment can enter the wound and surrounding tissues. A case report in the European Journal of Rheumatology described exactly this sequence: subcutaneous urate crystal deposits mechanically disrupted the skin surface, and the resulting opening led to a secondary bacterial infection with chronic wound drainage.²

Not every tophus ulcer becomes infected, but a significant proportion do. In a study of 38 patients with ulcers over tophi, nearly half had an active infection at the ulcer site. Those infected ulcers were larger, had been open much longer (about 126 days on average, compared to 54 days for uninfected ulcers), and showed more tissue death in the wound bed. Healing also took substantially longer when bacteria were present, averaging about 35 days compared with 20 days for uninfected wounds.³ The longer a tophus ulcer sits open, the higher the chance bacteria will colonize it, creating a feedback loop of infection and delayed closure.

Which Bacteria Are Typically Involved

When tophi ulcers do get infected, Staphylococcus aureus is the single most common culprit. In the same study of infected tophus ulcers, Staph aureus was found in half the infected cases. Other bacteria identified included Pseudomonas aeruginosa, Acinetobacter baumannii, and Shewanella algae, a waterborne organism more commonly seen in tropical or subtropical settings.³ Some wound infections over ruptured tophi are polymicrobial, meaning more than one species of bacteria is present at the same time. A case report documented a wound infection involving Providencia rettgeri, an unusual organism, growing alongside other bacteria from a tophus that had ruptured.⁴

This bacterial diversity matters for treatment. A standard antibiotic chosen for a typical skin infection may not cover the full range of organisms living in a tophus wound, especially in patients who have had repeated courses of antibiotics or live in warm climates where environmental bacteria are more varied. Wound cultures become particularly important in these cases rather than relying on empirical antibiotic choices.

Gout and Septic Arthritis in the Same Joint

One of the more dangerous intersections of gout and infection is when both conditions occur in the same joint at the same time. Septic arthritis, a bacterial infection inside a joint, is a medical emergency that can destroy cartilage and bone rapidly if untreated. A study spanning 15 years at a single hospital identified 30 hospitalized patients who had both positive bacterial cultures and urate crystals in the same joint.⁵ This coexistence is considered uncommon, but it may be underdiagnosed because once a doctor identifies gout crystals in the joint fluid, there is a natural tendency to stop investigating.

A UK database study found that people with gout developed septic arthritis at a rate of 0.24 cases per 1,000 person-years, compared with 0.09 cases per 1,000 person-years in people without inflammatory arthritis. After adjusting for other factors, gout patients were 2.6 times more likely to be diagnosed with septic arthritis that required antibiotics or hospitalization.¹ Several mechanisms likely contribute to this elevated risk. Damaged joint surfaces and chronic inflammation from repeated gout flares may make it easier for blood-borne bacteria to settle in the joint. The urate crystals themselves may also provide a physical surface for bacteria to latch onto and form biofilms, which can make the infection much harder to eradicate with antibiotics alone.

Why Gout Flares and Joint Infections Look So Similar

A major clinical problem is that a gout flare and a septic joint can look almost identical from the outside. Both produce a red, swollen, excruciatingly painful joint. Both can cause fever. Both can drive up white blood cell counts and inflammatory markers in the blood. In some cases, severe gout attacks trigger a systemic inflammatory response so intense that they mimic full-blown sepsis, with high fevers, racing heart rate, and dangerously abnormal blood work. One published case described a polyarticular gout attack that was indistinguishable from sepsis on clinical grounds alone.⁶

Gout with fever is particularly tricky. A study examining clinical features of acute gouty arthritis with fever found that the two conditions, gout-related fever and infection-related fever, are essentially indistinguishable on standard tests. Some patients with gout flares in the knee had such elevated white blood cell counts in their joint fluid that they were misdiagnosed with septic arthritis and treated with antibiotics they did not need.⁷ The reverse is equally dangerous: a patient with known gout who develops a septic joint may have the infection dismissed as “just another flare.” This is why experts recommend that joint fluid from any acute gouty attack should be sent for bacterial culture, even when crystals are clearly present and the fluid does not look overtly infected.⁵

Blood Tests That Help Tell Them Apart

Because gout and infection overlap so much on physical examination and standard blood work, clinicians have looked for better ways to distinguish them. Procalcitonin, a protein that tends to rise during bacterial infections but stays relatively low in non-infectious inflammation, has emerged as one of the more useful tools. In patients with acute gouty arthritis, average procalcitonin levels were dramatically lower than in patients with confirmed bacterial infection. Using a specific cutoff, procalcitonin correctly identified about 80 percent of cases on both sides, meaning it caught most infections and correctly cleared most gout flares.⁸

A separate study confirmed procalcitonin’s usefulness in everyday rheumatology practice, finding that it outperformed both C-reactive protein and white blood cell count in distinguishing septic arthritis from gout. At a cutoff of 0.5 ng/mL, the test was highly specific, meaning a high procalcitonin value strongly pointed toward bacterial infection.⁹ Procalcitonin is not perfect, and no single blood test replaces joint fluid culture, but when the clinical picture is ambiguous, it provides a meaningful additional signal. C-reactive protein, the marker doctors order most often during inflammatory episodes, is elevated in both conditions and therefore much less helpful at telling one from the other.

When Gout-Related Infections Turn Severe

In most cases, a tophus ulcer infection or a coincident joint infection can be managed with antibiotics and wound care if caught early. But when infections go unrecognized or untreated, the consequences escalate quickly. Bacteria from an infected tophus can spread into underlying bone, causing osteomyelitis. A case report described a patient with poorly controlled polyarticular tophaceous gout whose tophi penetrated into bone and caused osteomyelitis at those sites.¹⁰ Another case documented a patient whose tophus-related ulceration progressed to septic arthritis and osteomyelitis of a single finger, eventually leading to septic shock.¹¹

The most extreme reported outcomes involve ruptured tophi leading to sepsis and, in rare cases, hemophagocytic syndrome, a life-threatening condition in which the immune system goes into overdrive and begins attacking the body’s own blood cells. One case report described a patient whose ruptured ankle tophus led to repeated bouts of systemic inflammatory response during treatment, ultimately triggering hemophagocytic syndrome.¹² In another case, gout-induced septic arthritis spread through the bloodstream to form abscesses in the chest wall and mediastinum before progressing to sepsis, septic shock, and hemophagocytic syndrome. The authors attributed the severity in part to delayed recognition that infection was present alongside gout.¹³ These extreme cases are rare, but they underscore that gout-related infections are not a minor concern, particularly in elderly patients with large tophaceous deposits and limited mobility.

Why the Inflammatory Machinery of Gout Matters

Part of the reason gout makes infections both more likely and harder to spot is that gout itself is an intensely inflammatory disease. When urate crystals deposit in a joint, they activate an inflammatory signaling complex called the NLRP3 inflammasome inside white blood cells. This triggers production and release of interleukin-1-beta (IL-1β), one of the body’s most potent alarm signals. The result is rapid, severe inflammation that can rival what you would see during a genuine infection.¹⁴

This double-edged biology has two practical consequences. First, the inflammatory environment created by crystals damages local tissue, weakens the skin and joint lining over time, and may impair the immune system’s ability to contain bacteria that enter through those weakened areas. Second, because gout already produces such dramatic inflammation, the additional signal of an infection can be masked. A joint that was already producing massive amounts of inflammatory fluid and pain does not look noticeably different when bacteria join the party. This is the core of the diagnostic trap: the inflammation gout produces is real and severe, but it can hide a coexisting infection in plain sight.

Preventing Infection in People With Tophaceous Gout

The most effective way to prevent gout-related infections is to prevent tophi from forming in the first place, or to shrink existing ones. Urate-lowering therapy, the standard long-term treatment for gout, gradually dissolves urate deposits when it brings blood uric acid levels below the saturation point and keeps them there consistently. For most patients, this medical approach is sufficient. But a subset of patients develop tophi that cause complications, including infections and ulceration, despite medication. In those cases, surgical removal of tophi becomes an option, particularly when local infection is uncontrollable or a tophus is threatening critical structures.¹⁵

For people who already have tophi, practical wound prevention matters. Keeping the skin over tophi moisturized, protecting vulnerable areas from friction and pressure (especially on the feet and hands), and seeking care promptly for any skin breakdown over a tophus can reduce the window of opportunity for bacteria. If a tophus does ulcerate, early wound care and culture-guided antibiotic treatment offer the best chance of avoiding the complications described above.

Foot Ulcers and the Burden of Chronic Gout

The feet are among the most commonly affected sites for both gout flares and tophus formation, and they are also the area where gout-related ulcers cause the most functional damage. Foot ulcers in people with chronic gout tend to be long-lasting, and multiple ulcers can occur at the same time. Patients with these ulcers report moderate levels of foot pain, disability, and impairment, along with reduced quality of life. The combination of pain from the gout itself, reduced mobility from the ulcers, and the ongoing risk of infection creates a cycle that is difficult to break.¹⁶

People with diabetes are already familiar with the concept of foot ulcers as a serious medical concern, and gout-related foot ulcers share some of the same challenges: impaired healing, infection risk, and the need for ongoing monitoring. The key difference is awareness. Diabetic foot care programs are well established, but gout-related foot ulcers get far less attention from both patients and clinicians. If you have visible tophi on your feet, especially over pressure points like the big toe joint or the ankle, consider treating them with the same vigilance you would apply to any chronic wound risk.

Joint Injections and Procedural Risk

People with gout sometimes worry about whether joint injections, commonly used to treat flares with corticosteroids or to aspirate fluid for diagnosis, might introduce bacteria into an already vulnerable joint. The risk exists in theory, but in practice it is very low. A large study examining over 22,000 joint procedures, including both corticosteroid injections and fluid aspirations, found that only 11 patients developed septic arthritis afterward, a rate of about 0.08 percent. Risk factors for those few cases included older age, male sex, and pre-existing joint disease.¹⁷ For gout patients, the benefit of aspirating a swollen joint (both for crystal confirmation and to rule out infection) far outweighs the tiny procedural risk, especially given how important it is to distinguish between a flare and an infection.

Biofilms on Tophi

An area of growing interest is the role of biofilms in gout-related infections. Biofilms are communities of bacteria that attach to a surface and surround themselves with a protective matrix, making them resistant to both antibiotics and the body’s immune defenses. Urate crystal deposits appear to provide a surface where bacteria can form these biofilms, which may explain why some tophus-related infections are so difficult to clear with antibiotics alone.¹ When bacteria establish a biofilm on or within a tophus, standard courses of antibiotics may suppress the infection temporarily without fully eradicating it, leading to recurrent flare-ups of infection that mirror the recurrent flare-ups of gout itself. In some of these cases, surgical removal of the tophus is the only way to eliminate the reservoir of bacteria hiding inside it. This is one reason chronic tophaceous gout complicated by repeated infections is considered one of the strongest indications for surgical intervention rather than continued medical management alone.

1
PubMed Central. Septic Arthritis Complicating a Gout Flare: Report of Two Cases and Review of the Literature
2
PubMed Central. Ulcerated tophaceous gout
3
PubMed Central. Clinical characteristics of infectious ulceration over tophi in patients with gout
4
PubMed Central. A Case of Wound Infection with Providencia rettgeri and Coincident Gout in a Patient from Guam
5
Rheumatology. Concomitant septic and gouty arthritis—an analysis of 30 cases
6
The American Journal of Medicine. An Unusual Presentation of Severe Gout Mimicking Sepsis
7
PubMed Central. Clinical Features and Risk Factors of Fever in Acute Gouty Arthritis
8
PubMed Central. Serum Procalcitonin as a Useful Serologic Marker for Differential Diagnosis between Acute Gouty Attack and Bacterial Infection
9
PubMed. Value of serum procalcitonin for the diagnosis of bacterial septic arthritis in daily practice in rheumatology
10
Italian Journal of Medicine. Images in clinical medicine: gouty arthritis with osteomyelitis
11
PubMed Central. Rare Case of Gout Leading to Septic Arthritis, Osteomyelitis, and Septic Shock in an Elderly Patient
12
PubMed Central. Sepsis complicated with secondary hemophagocytic syndrome induced by giant gouty tophi rupture: A case report
13
Heliyon. Septic arthritis caused by gout progressed to sepsis and hemophagocytic syndrome
14
PubMed Central. Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
15
Seminars in Arthritis and Rheumatism. Treatment of tophaceous gout: When medication is not enough
16
PubMed Central. Clinical characteristics of foot ulceration in people with chronic gout
17
PubMed. Low frequency of septic arthritis after arthrocentesis and intra-articular glucocorticoid injection